The Latest Cardiac and Vascular News
YOKNEAM, Israel, May 7, 2019 /PRNewswire/ — Rapid Medical, a company focused on the development of next generation neurovascular devices, today announced that its Comaneci device received FDA clearance as a Temporary Coil Embolization Assist Device. The Comaneci is the first and only device in a new category of temporary coil embolization assist devices. […]
YOKNEAM, Israel, April 23, 2019 /PRNewswire/ — Rapid Medical, a company focused on the development of interventional neurovascular devices, announced today that it has completed an oversubscribed Series C financing of $20 million. The proceeds will be used for the completion of the TIGER U.S. IDE study and to support accelerating commercial growth […]
YOKNEAM, Israel, July 17, 2017 /PRNewswire/ — Rapid Medical, a company focused on the development of neurovascular interventional devices, announced today that it has completed a Series B financing of $9M to advance the commercialization of the company’s minimally invasive stroke treatment and prevention products, the TIGERTRIEVER Revascularization Device, and the COMANECI, Adjustable Remodeling Mesh. […]
